Methods for detecting aging conditions

By analyzing the microbial community structure of ocular surface tissue through 16S rRNA gene sequencing, the method provides objective biomarkers for detecting conjunctival diseases and aging states, enhancing disease prediction and treatment efficacy.

JP7594633B2Active Publication Date: 2024-12-04OSAKA UNIVERSITY +1
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2023111475
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-06-29
Filing Date
2023-07-06
Publication Date
2024-12-04
Estimated Expiration
2039-06-28

AI Technical Summary

Technical Problem

Current technologies lack the ability to objectively and reproducibly evaluate aging states and the onset of diseases such as conjunctival MALT lymphoma, with a need for reliable biomarkers that can predict disease progression and facilitate effective treatment strategies.

Method used

The method involves analyzing the microbial community structure of ocular surface tissue using 16S rRNA gene sequencing to identify changes in microbial flora, specifically detecting the abundance or ratio of bacterial species like Delftia, Bacteroides, and Clostridium, which are associated with conjunctival diseases, and using the ratio of Corynebacteriaceae to Propionibacteriales bacteria for aging biomarkers.

Benefits of technology

This approach allows for the objective and reproducible detection of conjunctival disease onset, risk, and progression, as well as aging states, reducing medical costs by enabling early detection and targeted treatments.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007594633000003
    Figure 0007594633000003
  • Figure 0007594633000004
    Figure 0007594633000004
  • Figure 0007594633000005
    Figure 0007594633000005
Patent Text Reader

Abstract

To provide construction of a technique that can evaluate an aging state or onset or progress or the like of a specific disease objectively and with good repeatability, which is particularly an aging biomarker being an indicator of an aging state, and a method for detecting an aging state.SOLUTION: An aging biomarker for detecting an aging state includes a bacterial species that belongs to one or more types of family selected from Corynebacteriaceae and Propionibacteriales in a superficial tissue of an eye, and a method for detecting an aging state includes a process of detecting a superficial tissue sample of an eye collected from a subject which is evaluated to be in an aging state when an abundance amount or an abundance ratio of Corynebacteriaceae bacterium exceeds an abundance amount or an abundance ratio of Propionibacteriales bacterium in a microbial flora included in the superficial tissue sample of an eye collected from the subject.SELECTED DRAWING: Figure 11
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to aging biomarkers and methods for detecting aging conditions using ocular surface tissue. [Background technology]

[0002] Factors that change quantitatively in correlation with the state of the living body or a specific disease are called biomarkers, and are indicators that can quantitatively grasp biological changes in the living body such as aging and disease. Factors that change quantitatively in correlation with age and can predict aging are called aging biomarkers, and factors that change quantitatively in correlation with a specific disease and can contribute to the diagnosis of the disease and the establishment of an efficient treatment are called disease biomarkers. In particular, in the current super-aging society, there are active efforts to understand the health and aging state of the elderly and extend their healthy lifespan, but there are few means to objectively and reproducibly evaluate the health and aging state, including aging biomarkers. At present, we are only able to confirm age-related changes specific to the elderly through blood tests and imaging diagnostics. For example, it has been reported that estrogen, testosterone, insulin-like growth factor-1, vitamin D, etc. in blood components change quantitatively in correlation with age. It is also known that the incidence of diseases such as lifestyle-related diseases and stroke increases with age.

[0003] In recent years, comprehensive gene expression analysis, such as transcriptome / metatranscriptome analysis, comprehensive metabolite analysis, and metagenomic analysis, such as comprehensive genome sequence analysis using a next-generation sequencer, have been performed. Attempts have been made to use these technologies in the comprehensive search for new biomarkers. For example, it has been reported that comprehensive genome analysis using a next-generation sequencer can be used to estimate the health and aging state of a subject from the presence ratio of indigenous bacteria on the skin surface, particularly Propionibacterium acnes (hereinafter sometimes abbreviated as "P. acnes") (see Patent Document 1). However, it has also been reported that the presence amount of P. acnes on the skin surface depends on physical conditions other than age, such as the oiliness of the skin, acne, thinning hair or hair loss, and menopause. Therefore, there is still a need to search for aging biomarkers that can objectively and reproducibly evaluate health and aging states.

[0004] Furthermore, disease biomarkers can contribute to the diagnosis of specific diseases and the establishment of efficient treatment methods. For example, in the field of ophthalmology, there is a need to clarify the mechanisms of onset of diseases whose incidence increases with age, such as conjunctival mucosa-associated lymphoid tissue (hereinafter abbreviated as "MALT") lymphoma, age-related macular degeneration, cataracts, and glaucoma, and to discover disease biomarkers that can predict onset.

[0005] Here, conjunctival MALT lymphoma is known as a localized low-grade tumor, and extranodal marginal zone B-cell lymphoma of the MALT type is the most common histological subtype. The frequency of lymphoma in the ocular accessory glands is estimated to be about 8% of extranodal lymphomas. The prognosis of primary conjunctival lymphoma has been reported to be good, with long-term survival expected among patients with primary lymphoma. Histologically, conjunctival MALT lymphoma has similar characteristics to gastric MALT lymphoma and is thought to result from a chronic inflammatory response. Helicobacter pylori DNA has been detected in some cases of conjunctival MALT lymphoma, and Chlamydia psittaci has been reported to be associated with its onset, so these bacterial species have been considered as possible causative pathogens. However, the pathophysiology of conjunctival MALT lymphoma has not been fully elucidated at present.

[0006] In the living body, a wide variety of resident microorganisms regulate and control homeostasis, and it is known that the microbiota present in the oral cavity, intestinal tract, respiratory tract, anus, and skin play an important role in maintaining health and in the onset and progression of diseases. In particular, in the human intestinal tract, more than 1,000 types of intestinal microorganisms form a unique stable environment as the intestinal microbiota and are involved in maintaining homeostasis of the living body. It has been discussed that such a change in the balance of the microbiota of the living body may cause abnormality in homeostasis and be involved in the onset and progression of diseases. For example, it has been reported that dysbiosis, which is an imbalance of the microbiota, is a trigger for systemic diseases such as inflammatory bowel disease, obesity, and cardiovascular disease. In addition, the relationship between the immune system and the resident microbiota of the living body in biodefense and tissue repair has also been reported. It has been shown that pathological changes in the microbiota of Staphylococcus epidermidis, a resident bacterium of the skin, cause opportunistic infections such as catheter infections, endocarditis of artificial valves, and endophthalmitis. Furthermore, the association between dysbiosis and central nervous system disorders such as autism, multiple sclerosis, anxiety-depression behavior, and functional gastrointestinal disorders has been reported at the clinical level, and the treatment of these conditions by targeting the microbiota has also been suggested. Thus, changes in the microbiota can cause various symptoms, including pathogen infection or inflammation, in the body, and may even lead to a fatal condition.

[0007] The ocular surface contains the conjunctiva-associated lymphoid tissue (CALT), which acts as a defense mechanism for the body. The ocular surface is continuously exposed to external environmental factors such as temperature changes, ultraviolet light, and oxidative stress, and these stresses are known to be involved in the development of pterygium, dry eye, corneal dystrophy, and Fuchs endothelial corneal dystrophy. This suggests that changes in the ocular surface microenvironment may lead to changes in the microbiota, which may ultimately lead to the development of diseases.

[0008] Based on this correlation between the microbiota and the onset of specific diseases, it may be possible to treat disease-induced changes in the microbiota as biomarkers and predict the onset and progression of the disease. However, it is not clear whether a stable microbiota like the intestinal microbiota exists in ocular surface tissue, and there is still insufficient knowledge about its association with specific diseases. [Prior art documents] [Patent documents]

[0009] [Patent Document 1] JP 2017-29133 A Summary of the Invention [Problem to be solved by the invention]

[0010] As mentioned above, conventionally, there are only reports at the research level of technology for objectively and reproducibly evaluating the aging state, and there is still a need to establish such technology. It is fundamentally difficult to define "aging," and it is desirable to objectively and reproducibly evaluate the overall picture of aging, including not only aging based on normal chronological age, but also pathological aging states that may lead to the onset of diseases in the future. In particular, quantitative evaluation of the aging state and the onset and progression of various diseases can be applied to the prevention of disease onset and the selection of effective treatment methods, which leads to the reduction of medical expenses and is also useful for the socio-economy.

[0011] Therefore, an objective of the present invention is to develop a technique capable of objectively and reproducibly evaluating the aging state and the onset and progression of a specific disease, and in particular, to provide a method for detecting conjunctival diseases such as conjunctival MALT lymphoma, and to provide an aging biomarker that serves as an indicator of the aging state. [Means for solving the problem]

[0012] As a result of repeated research to solve the above problems, the present inventors have found that dysbiosis of the conjunctival microflora may cause immunological changes in the conjunctival mucosa and may be involved in the onset of conjunctival MALT lymphoma. Subsequently, as a result of investigating the microbial community structure of the ocular surface tissue microflora in patients with conjunctival MALT lymphoma and healthy individuals, changes in the microbial community structure specific to patients with conjunctival MALT lymphoma were found, and it was found that the onset and progression of conjunctival MALT lymphoma can be detected based on such changes in the microbial community structure. Furthermore, it was also found that changes in the microbial community structure of the ocular surface tissue microflora can be used as an indicator of the aging state. Based on these findings, the present inventors have completed the present invention.

[0013] That is, the present invention provides the following inventions [1] to

[12] . [1] A method for detecting a conjunctival disease using an ocular surface tissue, comprising: A method for detecting a conjunctival disease, comprising a step of comparing a microbial community structure of a microbial flora contained in an ocular surface tissue specimen collected from a healthy subject with a microbial community structure of a microbial flora contained in an ocular surface tissue specimen collected from a subject, and detecting an ocular surface tissue specimen collected from the subject that is evaluated as having a conjunctival disease based on a change in the microbial community structure between the healthy subject and the subject.

[0014] According to the above-mentioned configuration [1], a method is provided for objectively and reproducibly detecting the onset, onset risk, and progression of conjunctival disease based on the change in the balance of the microflora present in the ocular surface tissue. Conventionally, it was not clear whether a microflora such as the intestinal microflora is stably present in the ocular surface tissue including the conjunctiva, and even more so whether a specific microflora is involved in conjunctival disease. However, the present inventors have clarified the relationship between the change in the balance of the microflora present in the ocular surface tissue and conjunctival disease. Therefore, according to this configuration, it is possible to quantitatively evaluate the onset and progression of conjunctival disease, including the early stage in which there are no subjective symptoms. This can be applied to the prevention of the onset of the disease and the selection of an effective treatment method, which leads to the reduction of medical expenses and is useful from the viewpoint of socio-economics. According to this configuration, since an ocular surface tissue sample is used, the sample can be collected more easily than blood sampling. Moreover, it has the advantage of being non-invasive and less mentally and physically burdensome.

[0015] [2] The method for detecting a conjunctival disease according to [1] above, wherein the conjunctival disease is conjunctival mucosa-associated lymphoid tissue lymphoma.

[0016] The above configuration [2] provides a method for objectively and reproducibly detecting the onset, risk of onset, and progression of conjunctival mucosa-associated lymphoid tissue lymphoma based on changes in the balance of the microbial flora present in the ocular surface tissue.

[0017] [3] The conjunctival disease detection method according to [2] above, wherein the change in the microbial community structure is a change in the abundance or abundance ratio of bacterial species belonging to one or more genera selected from the genera Delftia, Xylophilus, Simplicispira, Rothia, Xanthomonas, Bacteroides, Clostridium, Deinococcus, Williamsia, Parabacteroides, Chryseobacterium, Herbaspirillum, Brevundimonas, Lactobacillus, Schlegelella, and Exiguobacterium.

[0018] According to the above-mentioned configuration [3], the bacterial species is one whose abundance or abundance ratio has been confirmed to change due to the onset of conjunctival mucosa-associated lymphoid tissue lymphoma, etc. Based on the change in the abundance or abundance ratio of such bacterial species, a method is provided that can detect the onset, onset risk, and progression of conjunctival mucosa-associated lymphoid tissue lymphoma in a more objective and reproducible manner.

[0019] [4] The conjunctival disease detection method according to [3] above, wherein the change in the microbial community structure is a change in the abundance or abundance ratio of the bacterial species belonging to the genus Delftia, and an increase in the abundance or abundance ratio of the bacterial species belonging to the genus Delftia is evaluated as indicating the conjunctival disease.

[0020] According to the above-mentioned configuration [4], it has been confirmed that the abundance or the proportion of a bacterial species belonging to the genus Delftia increases due to the onset of conjunctival mucosa-associated lymphoid tissue lymphoma, etc. Based on the increase in the abundance or proportion of such a bacterial species, a method is provided that can detect the onset, onset risk, and progression of conjunctival mucosa-associated lymphoid tissue lymphoma in a more objective and reproducible manner.

[0021] [5] The conjunctival disease detection method according to [3] or [4] above, wherein the change in the microbial community structure is a change in the abundance or abundance ratio of one or more bacterial species selected from the genus Bacteroides and the genus Clostridium in the conjunctiva, and a decrease in the abundance or abundance ratio of one or more bacterial species selected from the genus Bacteroides and the genus Clostridium is evaluated as indicating the conjunctival disease.

[0022] According to the configuration of [5] above, it has been confirmed that the amount or proportion of bacterial species belonging to the genus Clostridium in the conjunctiva is reduced due to the onset of conjunctival mucosa-associated lymphoid tissue lymphoma, etc. Based on the reduction in the amount or proportion of such bacterial species, a method is provided that can more objectively and reproducibly detect the onset, onset risk, and progression of conjunctival mucosa-associated lymphoid tissue lymphoma.

[0023] [6] The conjunctival disease detection method according to any one of [1] to [5] above, wherein the change in the microbial community structure is evaluated based on the base sequence of the 16S rRNA gene of the microorganisms that constitute the microflora.

[0024] According to the above-mentioned configuration [6], a method is provided for objectively and reproducibly detecting the onset and progression of conjunctival disease based on the change in the balance of the microbial flora present in the ocular surface tissue by performing 16S rRNA gene analysis. According to this configuration, the microbial species present in the ocular surface tissue can be comprehensively analyzed by metagenomic analysis using a next-generation sequencer or the like without going through the isolation and culture step, and the microbial flora of the ocular surface tissue can be analyzed accurately and reliably. In other words, the microbial community structure of the microbial flora can be comprehensively analyzed without being biased toward specific microbial species, including microbial species that are difficult to culture and that are difficult to detect by conventional culture-based analysis, and the accuracy and reliability of the analysis results are improved. This further provides a method for accurately and reliably detecting the onset, onset risk, and progression of conjunctival mucosa-associated lymphoid tissue lymphoma.

[0025] [7] An aging biomarker for detecting an aging state, comprising a bacterial species belonging to one or more families selected from the Corynebacteriaceae family and the Propionibacteriales family in ocular surface tissue.

[0026] According to the above-mentioned configuration [7], an aging biomarker capable of evaluating the aging state by bacteria belonging to the Corynebacteriaceae family and the Propionibacteriales family present in the ocular surface tissue is provided. According to this configuration, the aging state of a subject can be detected objectively and reproducibly, and the aging state of the whole body can be detected from a sample collected from a local part of the eye. In the past, it was not clear whether a microflora such as the intestinal microflora exists stably in the ocular surface tissue including the conjunctiva, and even more so whether a specific microflora is involved in a conjunctival disease. However, the present inventors have clarified the relationship between the change in the balance of the microflora present in the ocular surface tissue and the aging state, and furthermore, the relationship with the onset of a specific disease. Therefore, the biomarker of this configuration can be used not only to detect the aging state, but also to detect the disease state that develops in relation to aging, and can be used to investigate the cause of a systemic disease that occurs as a result of age-related changes. In other words, it can be used to quantitatively evaluate not only the aging state, but also the onset, risk of onset, and degree of progress of a disease, including the early stage without subjective symptoms. As a result, the biomarker of this configuration can be applied to the prevention of disease onset and the selection of effective treatment methods, which will lead to reduced medical costs and be useful from a socioeconomic perspective.

[0027] [8] The aging biomarker according to [7] above, comprising the 16S rRNA gene of the bacterial species.

[0028] According to the above-mentioned configuration [8], an aging biomarker is provided that can objectively and reproducibly detect the aging state based on the change in the balance of the microflora present in the ocular surface tissue by performing 16S rRNA gene analysis. The 16S rRNA gene can be analyzed by metagenomic analysis using a next-generation sequencer or the like. According to such analysis, the microbial species present in the ocular surface tissue can be comprehensively analyzed without going through the isolation and culture step, and the microflora of the ocular surface tissue can be analyzed accurately and reliably. In other words, the microbial community structure of the microflora can be comprehensively analyzed without being biased toward specific microbial species, including microbial species that are difficult to culture, which are difficult to detect by conventional culture-based analysis, and the accuracy and reliability of the analysis results are improved. Therefore, according to the aging biomarker of this configuration, the aging state can be detected more accurately, reliably, objectively, and reproducibly.

[0029] [9] The aging biomarker according to [7] or [8] above, wherein the aging state is a physiological aging state or a pathological aging state.

[0030] The above-mentioned configuration [9] provides an aging biomarker that can detect not only physiological aging states (pre-disease states) based on chronological age, but also pathological aging states that cause pathological conditions due to abnormal acceleration of aging, etc. Therefore, the biomarker of this configuration can be used to detect not only aging states, but also disease states that develop in association with aging, and can be used to investigate the causes of systemic diseases that occur as a result of age-related changes.

[0031]

[10] A method for detecting an aging condition using an ocular surface tissue, comprising: A method for detecting an aging state, comprising a step of detecting an ocular surface tissue sample collected from a subject, the tissue sample being evaluated as being in an aging state when the abundance or abundance ratio of bacteria of the family Corynebacteriaceae exceeds the abundance or abundance ratio of bacteria of the family Propionibacteriales in a microbial flora contained in the ocular surface tissue sample collected from the subject.

[0032]

[11] The method for detecting an aging state according to

[10] above, wherein the amount or proportion of bacteria of the Corynebacteriaceae family or the amount or proportion of bacteria of the Propionibacteriales family is detected by determining the base sequence of the 16S rRNA gene of the bacteria and detecting it based on the base sequence.

[0033]

[12] The method for detecting an aging state according to claim

[10] or

[11] , wherein the aging state is a physiological aging state or a pathological aging state. [Brief description of the drawings]

[0034] [Figure 1] This is a graph showing the results of verifying the stability of bacterial composition among the four sites where samples were collected (conjunctiva, meibomian gland, periocular skin, and hands). [Figure 2A] 1 is a graph showing the results of an investigation into the effects of gender and left / right bias on the microbial community structure of the conjunctival microbiota, showing the results for a healthy group. [Figure 2B] 13 is a graph showing the results of an investigation into the influence of gender and left / right bias on the microbial community structure of the conjunctival microbiota, showing the results for the disease group. [Diagram 3] This is a graph showing the results of examining the alpha diversity of the microbiota among the four sites where samples were collected (conjunctiva, meibomian gland, periocular skin, and hands). [Figure 4A] This is a graph showing the results of PCA analysis of the beta diversity of the microbiota among the four sites where samples were collected (conjunctiva, meibomian gland, periocular skin, and hands), and shows the results for the healthy group. [Figure 4B] This is a graph showing the results of PCA analysis of the alpha diversity of the microbiota among the four sites where samples were collected (conjunctiva, meibomian gland, periocular skin, and hand), and shows the results for the disease group. [Diagram 5] FIG. 1 shows the results of examining the differences in bacterial composition of the microbial flora among the four sites from which samples were collected (conjunctiva, meibomian gland, periocular skin, and hands), and includes a bar graph showing LDA scores and a phylogenetic tree diagram plotting the LDA scores. [Figure 6A]This shows the results of a more detailed examination of the differences in bacterial composition between the microbial flora derived from healthy and disease groups, and is a box plot showing the proportion of each bacterial species, with the results showing bacterial species that were statistically more prevalent in the disease group than in the healthy group. [Figure 6B] This shows the results of a more detailed examination of the differences in bacterial composition between the microbial flora derived from healthy and disease groups, and is a box plot showing the proportion of each bacterial species, showing the results of bacterial species that were statistically lower in the disease group than in the healthy group. [Figure 7] FIG. 1 is a box plot showing the results of examining the differences in tear properties between healthy and diseased groups, and shows the results of measuring tear pH. [Figure 8] FIG. 1 is a box plot showing the results of examining the differences in tear properties between healthy and diseased groups, and shows the results of measuring tear IgA concentration. [Figure 9] The results of comparing the fungal composition of the microbial flora in samples collected from the conjunctiva between healthy and disease groups are shown, with the proportion of each fungal species present. [Figure 10A] This is a box plot showing the results of a more detailed examination of the differences in the bacterial composition of the conjunctival microbial flora derived from the healthy and disease groups, comparing the abundance of the genus Malassezia, which had the highest abundance ratio, between the healthy and disease groups. [Figure 10B] FIG. 1 is a box plot showing the results of a more detailed examination of the differences in the bacterial composition of the conjunctival microbial flora derived from healthy and disease groups, comparing the abundance of the Byssochlamys genus, which had the highest abundance ratio, between the healthy and disease groups. [Figure 10C] FIG. 1 shows a box plot illustrating the results of a more detailed examination of the differences in the bacterial composition of the conjunctival microbial flora derived from healthy and diseased groups, comparing the abundance of the Aspergillus genus, which had the highest abundance ratio, between the healthy and diseased groups. [Figure 11] 1 is a graph showing age-related changes in the occupancy rate of Propionibacteriaceae and Corynebacteriaceae bacteria in the conjunctiva. [Figure 12] 1 is a graph showing the change in the ratio of bacteria of the family Corynebacteriaceae to bacteria of the family Propionibacteriaceae (C / P) with age. [Figure 13] 1 is a graph showing the change in the difference (CP) between the family Corynebacteriaceae and the family Propionibacteriaceae with age. [Figure 14] This is a graph showing the change with age in the difference (CP) between the Corynebacteriaceae family and the Propionibacteriaceae family in the four sites where samples were taken (conjunctiva, meibomian glands, periocular skin, and hands). DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0035] Hereinafter, a conjunctival disease detection method and an aging biomarker using ocular surface tissue according to an embodiment of the present invention will be described in detail. However, the present invention is not limited to the embodiments described below.

[0036] (Method for detecting conjunctival diseases) The conjunctival disease detection method according to the present embodiment provides information on the morbid state of conjunctival disease based on a change in the balance of the microbiota present in the ocular surface tissue. That is, the conjunctival disease detection method according to the present embodiment is based on the finding that a change in the microbial community structure of the microbiota present in the ocular surface tissue correlates with the pathological condition of the conjunctival disease.

[0037] The conjunctival disease to be detected by the conjunctival disease detection method according to the present embodiment refers to all diseases that cause conjunctival abnormalities. In particular, it includes diseases that cause abnormalities in the conjunctiva as a result of age-related changes, and diseases whose incidence rate increases with age. Examples of such diseases include conjunctival MALT lymphoma, pterygium, dry eye, conjunctival chalazion, glaucoma, and age-related macular degeneration (AMD).

[0038] The conjunctival disease detection method according to this embodiment detects the onset and progression of a conjunctival disease based on a change in the microbial community structure of a microbial flora contained in an ocular surface tissue specimen derived from a subject. That is, an ocular surface specimen collected from a subject evaluated to have a conjunctival disease based on a change in the microbial community structure of the microbial flora can be detected, and thus it can be detected whether or not the subject has developed a conjunctival disease, whether or not there is a risk of developing a conjunctival disease in the future, etc.

[0039] The ocular surface tissue includes tissues on the surface of the eyeball and adnexa, which are structures close to the surface of the eyeball. The eyeball is protected by the eyelids and the eyelashes at the upper and lower edges of the eyelids, and its outer membrane is composed of the cornea and sclera. The sclera from the inside of the eyelid to the front of the eyeball is covered by the conjunctiva, and the Tenon's capsule is located between the conjunctiva and the sclera. The conjunctiva includes the palpebral conjunctiva, which covers the inside of the eyelids, the bulbar conjunctiva, which covers part of the front of the eyeball, and the fornix conjunctiva, which is the transition between the two. Furthermore, the meibomian gland opens at the eyelid margin, the lacrimal gland opens at the ear side of the superior conjunctival fornix, and the accessory lacrimal gland opens at the upper and lower conjunctival fornix. Examples of ocular surface tissue include, but are not limited to, those mentioned above. The ocular surface tissue also includes secretions from the ocular surface tissue described above, such as the tear film composed of an oily layer and a liquid layer (a mucin layer and an aqueous layer), ocular mucus, leakage and exudate from blood vessels, etc., and cells and tissue fragments such as exfoliated epithelial cells.

[0040] Ocular surface tissue samples can be collected using techniques known in the art as long as they can collect bacteria present in the ocular surface tissue. For example, they can be collected by scraping the ocular surface tissue with a swab (cotton swab) or spatula under sterile conditions (ocular surface tissue scraping sample), and by collecting secretions such as leakage and exudation from the ocular surface tissue (ocular surface tissue secretion sample). When collecting the ocular surface tissue, local anesthesia or the like may be administered as necessary. The obtained ocular surface tissue sample can be dissolved or suspended in an appropriate liquid as necessary. The amount of the ocular surface tissue sample to be collected is not particularly limited, but may be, for example, the amount obtained by scraping with one swab. In this way, the ocular surface tissue sample can be collected by a simple and non-invasive method such as scraping the ocular surface tissue.

[0041] In the conjunctival disease detection method according to the present embodiment, the change in the microbial flora present in the ocular surface tissue can be determined using a technique known in the art. For example, a microbial flora analysis method targeting the 16S rRNA gene can be used. Examples of the microbial flora analysis method include metagenomic analysis, terminal restriction fragment length polymorphism (T-RFLP), denaturing gradient gel electrophoresis (DGGE), temperature gradient gel electrophoresis (TGGE), and fluorescence in situ hybridization (FISH)-flow cytometry (FISH-FCM), but are not limited thereto. In particular, a metagenomic analysis method using a next-generation sequencer can be used.

[0042] When using metagenomic analysis, for example, the base sequence of the 16S rRNA gene of microorganisms, particularly bacteria, contained in the ocular surface tissue sample of a subject can be analyzed, and an ocular surface tissue sample collected from a subject who has been evaluated as having a conjunctival disease can be detected based on the obtained base sequence data. By using a next-generation sequencer, it is possible to identify the microbial species and their abundance ratio as a single group of microbial flora, which was difficult to identify using conventional culture methods. Therefore, since there is no need to go through the isolation and culture step, it is possible to comprehensively analyze the microbial species contained in the entire collected sample without being biased toward specific microbial species, including difficult-to-culture microbial species that were difficult to detect using conventional culture-based analysis. Furthermore, it is possible to taxonomically identify microbial species by comparing with existing databases, and to perform characteristic analysis of the microbial community structure.

[0043] In the analysis of the base sequence of the 16S rRNA gene, first, the genomic DNA of the microorganism contained in the ocular surface tissue sample of the subject is extracted. The method of extracting bacterial genomic DNA is not particularly limited, and can be performed using a technique known in the art. For example, a heat extraction method, an alkaline heat extraction method, a phenol-chloroform extraction method, etc. can be used. In addition, a commercially available extraction kit such as PowerSoil (registered trademark) DNA Isolation Kit (MoBio, Carlsbad, CA) can be used.

[0044] Next, the base sequence of the 16S rRNA gene contained in the extracted genomic DNA is determined. The 16S rRNA gene may be sequenced over the entire region, but it is preferable to sequence a specific region as long as the sequence characteristics between each microbial species are reflected. The 16S rRNA gene is adjacent to nine hypervariable regions called V1-V9, which are ubiquitous in regions that are highly conserved across microbial species. By subjecting such hypervariable regions to base sequencing, it is possible to identify the microbial species. Therefore, it is preferable to determine the base sequence of any one of the hypervariable regions or a region containing a plurality of these regions. For example, a region containing V1-V2 or a region containing V3-V4 can be mentioned, but the present invention is not limited to such regions.

[0045] When determining the base sequence, the region to be determined may be amplified as necessary, and the obtained nucleic acid amplified fragment (amplicon) may be the subject of base sequence determination. Nucleic acid amplification can be performed using a technique known in the art. For example, polymerase chain reaction (PCR) or the like can be used. Primers used in the nucleic acid amplification reaction can be designed based on a technique known in the art. It is preferable to design the primer so as to include a region that is relatively universally conserved among the 16S rRNA genes of bacteria in the ocular surface tissue, and for example, a universal primer for the 16S rRNA gene can be used. The primer may be designed so as to add a sequence required for base sequence determination to the amplified nucleic acid fragment. For example, a barcode sequence for use in identifying samples can be used.

[0046] When determining the base sequence, the amplified nucleic acid fragment may be purified in advance by a technique known in the art. The base sequence may be determined by any technique known in the art. For example, the base sequence may be determined by a sequencer based on the conventional Sanger method, but from the viewpoint of the ability to analyze the base sequence, it is preferable to use a next-generation sequencer based on the Sequencing by Synthesis method, the Pyrosequencing method, the Ligase Reaction Sequencing method, etc. As the next-generation sequencer, for example, MiSeq (Illumina) can be used, and the sequence can be determined according to the manufacturer's protocol.

[0047] Since the obtained base sequence data (reads) may contain low-quality reads due to incomplete sequencing reactions, etc., low-quality reads may be removed by read trimming, if necessary. Trimming can be performed using, for example, BBtrim.

[0048] The microbiota is analyzed based on the sequenced base sequence. The microbiota can be analyzed by using any technique known in the art, and can be analyzed by visualizing or quantifying the microbial community structure of the microbiota, for example, principal component analysis (PCA) or principal coordinate analysis (PCoA) can be used. The microbiota can be analyzed by using analysis software or databases known in the art. For example, QIIME can be used as the analysis software, and for example, Greengenes, SILVA, NCBI, etc. can be used as the database, and homology analysis, phylogenetic analysis, etc. are performed on the database.

[0049] The obtained base sequence data may be classified into a plurality of clusters based on sequence similarity by OTU (Operational Taxonomic Unit) analysis, and the base sequence that appears most frequently in each OUT may be set as a representative sequence, and analysis may be performed using the representative sequence. In this case, the similarity of base sequences for classification into the same cluster may be appropriately set based on the required reliability, etc., and may be, for example, 95% or more, 97% or more, or 99% or more. UCLUST, UPARSE, USEARCH, etc. may be used as software for OTU analysis.

[0050] A conjunctival disease is detected by comparing the microbial community structure of the microbiota derived from the ocular surface tissue of a subject with that derived from a healthy subject. Here, the microorganism includes bacteria or fungi, and bacteria are particularly preferred. For example, the abundance or abundance ratio of bacteria belonging to a specific phylum, class, order, family, genus, or species in the bacteria constituting the microbiota derived from the ocular surface tissue can be used as an index. If it is determined that the abundance or abundance ratio of the subject is significantly increased or decreased compared to a healthy subject, it can be determined that the subject suffers from a conjunctival disease or is at risk of developing a conjunctival disease in the future. Here, the abundance ratio can be the ratio, difference, sum, or product of the abundance ratios of multiple bacteria belonging to a specific phylum, class, order, family, genus, or species. In this case, the determination of whether the abundance or abundance ratio of the subject is significantly increased or decreased compared to a healthy subject can be performed by setting a reference value for the abundance or abundance ratio of bacteria belonging to a specific phylum, class, order, family, genus, or species in the microbiota derived from the ocular surface tissue in advance and comparing it with the reference value. It may also be based on statistical differences between subjects in the amount or proportion of bacteria belonging to a particular phylum, class, order, family, genus, or species. In this case, the determination of the presence of a conjunctival disease may be made at any level of bacterial phylum, class, order, family, genus, or species. It may also be a determination based on a single phylum, class, order, family, genus, or species level, or a determination based on multiple phylum, class, order, family, genus, or species levels.

[0051] For example, conjunctival MALT lymphoma can be determined based on changes in the microbial community structure of the ocular surface tissue, particularly the conjunctiva, using an increase in the abundance or abundance ratio of bacteria belonging to the following genera as an index compared to healthy subjects. If the abundance or abundance ratio of the following bacteria is increased compared to healthy subjects, it can be determined that the subject has developed conjunctival MALT lymphoma or is at risk of developing conjunctival MALT lymphoma in the future. Bacteria of the genus Delftia (phylum Proteobacteria, order Betaproteobacteria, order Burkholderiales, family Comamonadaceae, genus Delftia) Bacteria of the genus Xylophilus (phylum Proteobacteria, order Gamma Proteobacteria, order Xanthomonadales, family Xanthomadaceae, genus Xylophilus) Bacteria of the genus Simplicispira (phylum Proteobacteria, order Betaproteobacteria, order Burkholderiales, family Comamonadaceae, genus Simplicispira) Bacteria of the genus Rothia (phylum Actinobacteria, family Actinobacteria, order Micrococcales, family Micrococcaceae, genus Rothia) Bacteria of the genus Xanthomonas (phylum Proteobacteria, family Gammaproteobacteria, order Xanthomonadales, family Xanthomonadaceae, genus Xanthomonas)

[0052] Particularly preferably, conjunctival MALT lymphoma can be determined using an increase in the amount or proportion of Delftia bacteria as an index. Here, Delftia bacteria are aerobic gram-negative bacilli. Delftia bacteria are resistant to β-lactam and aminoglycoside antibiotics. They are known to attach to contact lens cases to form biofilms, leading to the development of microbial and invasive keratitis on the ocular surface. Delftia bacteria also have the ability to oxidatively decompose and utilize glucose. This may cause changes in the conjunctival environment, and it is known that some corneal abnormalities, such as abnormalities in the corneal epithelium, are caused by changes in glucose levels. Therefore, Delftia bacteria may cause conjunctival MALT lymphoma as an attacking factor by changing the condition of the conjunctiva and interfering with CALT.

[0053] Furthermore, the determination of conjunctival MALT lymphoma based on changes in the microbial community structure of the ocular surface tissue, particularly the conjunctiva, can be performed using a decrease in the abundance or abundance ratio of bacteria belonging to the following genera as an index compared to healthy subjects. If the abundance or abundance ratio of the following bacteria is decreased compared to healthy subjects, it can be determined that the subject has developed conjunctival MALT lymphoma or is at risk of developing conjunctival MALT lymphoma in the future. Bacteroides genus bacteria (phylum Bacteroidetes, family Bacteroidea, order Bacteroidales, family Bacteroidaceae, genus Bacteroides) Bacteria of the genus Clostridium (phylum Firmicutes, class Clostridia, order Clostridiales, family Clostridiaceae, genus Clostridium) Bacteria of the genus Deinococcus (phylum Deinococcus-Thermus, family Deinococci, order Deinococcales, family Deinococcaceae, genus Deinococcus) Bacteria of the genus Williamsia (phylum Actinobacteria, class Actinobacteria, order Corynebacteriales, family Williamsiaceae, genus Williamsia) Bacteria of the genus Parabacteroides (phylum Bacteroidetes, family Bacteroidea, order Bacteroidales, family Tannerellaceae, genus Parabacteroides) Bacteria of the genus Chryseobacterium (phylum Bacteroidetes, class Flavobacteriia, order Flavobacteriales, family Flavobacteriaceae, genus Chryseobacterium) Bacteria of the genus Herbaspirillum (phylum Proteobacteria, order Betaproteobacteria, order Burkholderiales, family Oxalobacteraceae, genus Herbaspirillum)

[0054] Particularly preferably, conjunctival MALT lymphoma can be determined using a decrease in the abundance or proportion of Bacteroides and Clostridium bacteria as an indicator. Here, Bacteroides bacteria are known to produce bacterial polysaccharides and direct the maturation of cells of the immune system and the body during development. In the small intestine, Bacteroides interacts with dendritic cells in the intestinal Peyer's patches and induces the production and maturation of immunoglobulin A as a defense mechanism known as gut-associated lymphoid tissue (GALT). Thus, the presence of Bacteroides bacteria from birth is essential to maintain homeostasis of the intestinal immune system, and may be useful as a local defense mechanism for ocular surface tissues as well. It has also been reported that mucosa-associated Clostridium bacteria populations play an important role in the induction of Tregs and IgA, and in the suppression of inflammatory and allergic responses. In view of the above, it can be understood that this suggests that beneficial microbial groups such as Bacteroides and Clostridium bacteria govern the suppression of inflammatory and allergic responses as defense factors.

[0055] Furthermore, the determination of MALT lymphoma based on changes in the microbial community structure of ocular surface tissues, particularly the meibomian glands, can be performed using an increase in the abundance or abundance ratio of bacteria belonging to the following genera as an index compared to healthy subjects. If the abundance or abundance ratio of the following bacteria is increased compared to healthy subjects, it can be determined that the subject has developed conjunctival MALT lymphoma or is at risk of developing conjunctival MALT lymphoma in the future. Bacteria of the genus Delftia (phylum Proteobacteria, order Betaproteobacteria, order Burkholderiales, family Comamonadaceae, genus Delftia) Bacteria of the genus Clostridium (phylum Firmicutes, class Clostridia, order Clostridiales, family Clostridiaceae, genus Clostridium) Bacteria of the genus Brevundimonas (phylum Proteobacteria, group Alphaproteobacteria, order Caulobacterales, family Caulobacteraceae, genus Brevundimonas)

[0056] Furthermore, the determination of MALT lymphoma based on changes in the microbial community structure of the ocular surface tissue, particularly the meibomian gland, can be performed using a decrease in the abundance or abundance ratio, etc. of bacteria belonging to the following genera in healthy subjects as an indicator. If the abundance or abundance ratio, etc. of the following bacteria is decreased compared to healthy subjects, it can be determined that the subject has developed conjunctival MALT lymphoma or is at risk of developing conjunctival MALT lymphoma in the future. Bacteria of the genus Lactobacillus (phylum Firmicutes, order Bacilli, order Lactobacillales, family Lactobacillaceae, genus Lactobacillus) Bacteria of the genus Schlegelella (phylum Proteobacteria, order Betaproteobacteria, order Burkholderiales, family Comamonadaceae, genus Schlegelella)

[0057] Furthermore, the determination of MALT lymphoma based on changes in the microbial community structure of the ocular surface tissue, particularly the periocular skin, can be performed using an increase in the abundance or abundance ratio of bacteria belonging to the following genera as an index compared to healthy subjects. If the abundance or abundance ratio of the following bacteria is increased compared to healthy subjects, it can be determined that the subject has developed conjunctival MALT lymphoma or is at risk of developing conjunctival MALT lymphoma in the future. Bacteria of the genus Delftia (phylum Proteobacteria, order Betaproteobacteria, order Burkholderiales, family Comamonadaceae, genus Delftia)

[0058] Furthermore, the determination of MALT lymphoma based on changes in the microbial community structure of the ocular surface tissue, particularly the periocular skin, can be performed using a decrease in the abundance or abundance ratio of bacteria belonging to the following genera as an index compared to healthy subjects. If the abundance or abundance ratio of the following bacteria is decreased compared to healthy subjects, it can be determined that the subject has developed conjunctival MALT lymphoma or is at risk of developing conjunctival MALT lymphoma in the future. Bacteria of the genus Exiguobacterium (phylum Firmicutes, class Bacilli, order Bacillales, family Bacillaceae, genus Exiguobacterium)

[0059] In the microbiota constituting the microbiota derived from ocular surface tissue, the similarity distance between specific groups can be used as an index, and when it is determined that the similarity distance between the microbiota of a subject and a healthy person is a certain distance or more, it can be determined that the subject has developed a conjunctival disease or is at risk of developing a conjunctival disease in the future. For example, UniFrac distance analysis can be used. In such an analysis method, a phylogenetic tree analysis is performed using representative OTU sequences of the microbiota derived from the ocular surface tissue of a subject and a healthy person to be compared, and the difference in the microbial community structure is calculated as a distance (UniFrac distance) from the length of the branch of the OTU shared between both microbiota and the ratio of the branch unique to each microbiota, and the similarity between the microbiota can be expressed as a distance (UniFrac distance) of 0 (100% similar) to 1 (100% dissimilar). Furthermore, a two-dimensional scatter diagram may be created by principal coordinate analysis based on the UniFrac distance. The determination of whether the similarity distance between the microbiota of the subject and that of a healthy individual is equal to or greater than a certain distance can be determined, for example, by comparing the similarity distance of the subject with reference data and determining whether the similarity distance of the subject is closer to a group with conjunctival disease or to a group of healthy individuals. If the distance to the group with conjunctival disease is closer, it can be determined that the subject has developed a conjunctival disease or is at risk of developing a conjunctival disease in the future. In addition, the above-mentioned two-dimensional scatter plot can be used, and if the microbiota of the subject is located relatively closer to the group with conjunctival disease than to the healthy individual group on the two-dimensional scatter plot, it can be determined that the subject has developed a conjunctival disease or is at risk of developing a conjunctival disease in the future.

[0060] In the conjunctival disease detection method according to the present embodiment, the microbial species that can be used as an indicator of changes in the microbial community structure of the ocular surface tissue can be used as a disease biomarker for detecting conjunctival diseases, and such a disease biomarker also forms part of the present invention. In addition, the method can be used as a conjunctival disease detection kit for detecting conjunctival diseases by detecting changes in the microbial community structure, and such a disease detection kit also forms part of the present invention. For example, the method can be configured to include an oligonucleotide probe or primer for a gene specific to a microorganism, or a specific antibody, etc.

[0061] (Aging biomarkers) The aging biomarker according to the present embodiment provides information on the aging state of a living organism based on a change in the balance of the microbiota present in the ocular surface tissue. That is, the aging biomarker according to the present embodiment is based on the finding that a change in the microbial community structure of the microbiota present in the ocular surface tissue correlates with aging.

[0062] The aging biomarker according to the present embodiment means a factor that varies depending on aging, i.e., the passage of life time, and can predict the aging state, such as the degree of aging. Aging is a change in biological ability that occurs after maturity, and means a decline in function that appears at all levels of individuals, organs, tissues, and cells, and includes not only aging based on chronological age but also aging based on biological age. In addition, aging does not matter whether it is physiological aging or pathological aging. Therefore, the aging biomarker according to the present embodiment is an indicator of not only physiological aging state but also pathological aging state. Here, physiological aging means a decline in physiological function that inevitably progresses with aging, and pathological aging means a decline in function that causes a pathological state due to abnormal acceleration of aging, etc.

[0063] The aging biomarker according to the present embodiment is an index of a pathological aging state, and can therefore be used as an index of the onset and progression of diseases that cause abnormalities in the body as a result of age-related changes. Examples of such diseases include diseases whose incidence increases with age, such as conjunctival MALT lymphoma, pterygium, dry eye, conjunctival chalasis, glaucoma, and age-related macular degeneration (AMD).

[0064] The aging biomarker according to the present embodiment is an index of a change in the microbial community structure of the microbiota in an ocular surface tissue specimen derived from a subject. Details of the ocular surface tissue specimen and the method for collecting the same are as described above in the section (Method for detecting conjunctival disease).

[0065] Detection of changes in the microbial flora in an ocular surface tissue sample using the biomarker according to this embodiment can be carried out using techniques known in the art, the details of which are as described above in the section (Method for detecting conjunctival disease).

[0066] The aging biomarker according to the present embodiment is an index of changes in the microbial community structure of the microbiota derived from the ocular surface tissue of a subject. For example, bacteria that belong to a specific phylum, class, order, family, genus, or species whose abundance or abundance ratio varies depending on age among bacteria that constitute the microbiota derived from the ocular surface tissue can be used as the aging biomarker. Here, the abundance ratio can be the ratio, difference, sum, or product of the abundance ratio of multiple bacteria that belong to a specific phylum, class, order, family, genus, or species. The aging biomarker may be bacteria at any level of phylum, class, order, family, genus, or species. In addition, it may be bacteria at one phylum, class, order, family, genus, or species level, or bacteria at multiple phylum, class, order, family, genus, or species level.

[0067] For example, bacteria belonging to the following families can be used as aging biomarkers, all of which are indigenous to ocular surface tissues: Bacteria of the family Corynebacteriaceae (phylum Actinobacteria, family Actinobacteria, order Corynebacteriales, family Corynebacteriaceae) Bacteria of the family Propionibacteriales (phylum Actinobacteria, family Actinobacteria, order Propionibacteriales, family Propionibacteriales)

[0068] The abundance and abundance ratio of bacteria of the Corynebacteriaceae family and bacteria of the Propionibacteriales family correlate with the aging state of a living organism. In detail, the abundance and abundance ratio of bacteria of the Corynebacteriaceae family increases with age, while the abundance and abundance ratio of bacteria of the Propionibacteriales family decreases with age. Therefore, bacteria of the Propionibacteriales family are predominant in the younger age group, while bacteria of the Corynebacteriaceae family are predominant in the older age group. Therefore, when the abundance and abundance ratio of bacteria of the Propionibacteriales family are predominant in a subject's ocular surface tissue sample, the subject can be determined to be in an aging state, and conversely, when the abundance and abundance ratio of bacteria of the Corynebacteriaceae family are predominant, the subject can be determined to be not in an aging state.

[0069] Specifically, the ratio of the abundance of a plurality of bacteria whose abundance varies depending on age can be used as an aging biomarker. For example, the ratio of Propionibacteriaceae bacteria / Corynebacteriaceae bacteria can be used as an aging biomarker. When such a ratio is high, it can be determined that the subject is in an aging state. For example, a cutoff value can be set in the Propionibacteriaceae bacteria / Corynebacteriaceae bacteria ratio to determine the aging state of the subject. Since the abundance and abundance ratio of Propionibacteriaceae bacteria are high in young people and the abundance and abundance ratio of Corynebacteriaceae bacteria increase with aging, if the value is smaller than the set cutoff value, it can be determined that the subject is in an aging state. The cutoff value can be appropriately set according to the purpose of detection, and can be set to 1, for example. Specifically, the difference in the abundance ratio of a plurality of bacteria whose abundance varies depending on age can be used as an aging biomarker. For example, the difference between Propionibacteriaceae bacteria and Corynebacteriaceae bacteria can be used as an aging biomarker. When the difference is small, it can be determined that the subject is in an aging state. Therefore, a cutoff value can be set in the Propionibacteriaceae bacteria-Corynebacteriaceae bacteria difference to determine the aging state of the subject. If the difference is smaller than the set cutoff value, it can be determined that the subject is in an aging state. The cutoff value can be appropriately set according to the detection purpose, and can be set to 0, for example. Furthermore, the degree of aging (for example, aging +5 years compared to the actual age) can be determined based on the Propionibacteriaceae bacteria / Corynebacteriaceae bacteria ratio and / or the Propionibacteriaceae bacteria-Corynebacteriaceae bacteria difference. That is, the aging state includes not only a qualitative assessment of an aging state in which the risk of conjunctival disease is high, but also a method of quantitatively assessing the degree of aging relative to the actual age.

[0070] In the microbiota that constitutes the microbiota derived from the ocular surface tissue, the similarity distance between specific groups can be used as an index, and when it is determined that the similarity distance between the microbiota of a subject and, for example, a young healthy person is equal to or greater than a certain distance, it can be determined that the subject is in an aging state, etc. For example, UniFrac distance analysis or the like can be used, the details of which are as described above in the section (Method for detecting conjunctival disease).

[0071] The aging biomarker according to the present embodiment can be used to detect the aging state (risk of conjunctival disease) of a subject, and such a method for detecting an aging state also constitutes a part of the present invention. For example, the method includes a step of comparing the microbial community structure of a microbiota contained in an ocular surface tissue specimen collected from a healthy young person with the microbial community structure of a microbiota contained in an ocular surface tissue specimen collected from a subject, and detects an ocular surface tissue specimen that is evaluated as being in an aging state based on the change in the microbial community structure between the healthy young person and the subject, and the biomarker according to the present embodiment can be used as an index when the microbial community structure changes. The details of the steps can be performed in accordance with the above section (Conjunctival disease detection method). EXAMPLES

[0072] [Example 1] Changes in the microbial flora (bacterial flora) in conjunctival MALT lymphoma In this example, we investigated the relationship between changes in the ocular surface tissue microbiota and the onset of conjunctival MALT lymphoma. Specifically, we analyzed the microbial community structure (bacteria) contained in samples collected from human ocular surface tissue using the 16S rRNA gene and compared the results between healthy subjects and patients with conjunctival MALT lymphoma.

[0073] [Disease group and healthy group] The disease group consisted of 25 patients (50 eyes) diagnosed with conjunctival MALT lymphoma by biopsy at Osaka University Hospital between 2015 and 2017 (Table 1). The disease group excluded those with obvious ocular surface disease, those with a recent history of contact lens wear, those with a history of taking systemic or local antibiotics or ophthalmic prescription drugs in the past 12 months, those with a history of ocular surgery in the past 12 months, those with ocular infections, those with dry eye symptoms, those with systemic diseases such as diabetes, and those who smoke. The disease group consisted of 7 men and 18 women, with a mean age of 61.7 ± 15.6 years. As a control, 25 healthy volunteers (50 eyes) were examined in the healthy group in the same way. The healthy group consisted of 7 men and 18 women, with a mean age of 58.3 ± 13.0 years. The clinical data and background of the disease group are shown in Table 1. Of the 25 patients in the disease group, 5 had a history of chemotherapy and radiation therapy, 6 had only chemotherapy, and 3 had only radiation therapy. Five patients had gastric lesions (2 gastric MALT lymphoma, 1 gastric polyp, 1 gastric ulcer, and 1 gastric cancer). The mean follow-up period was 50.0±6.2 months (range, 5-93 months).

[0074] [Table 1]

[0075] 〔method〕 (Sample collection and DNA isolation) Samples were collected in a clean room for ophthalmic treatment. Samples were collected from the superior and inferior conjunctival fornix of both eyes using DNA swabs (Osaki Sterilized Cotton Swabs S0475-10, JAPAN) after instilling sterile local anesthetic proparacaine into the eyes of each individual in the disease and healthy groups at baseline and one month later. To compare the conjunctiva with other sites, samples were similarly collected from the hands, meibomian glands, and periocular skin. Thus, the following experiments were performed on samples collected from four sites: the conjunctiva, hands, meibomian glands, and periocular skin. Each sample was transferred to a tube (Eppendorf, Fremont, CA) and frozen at -80°C until DNA extraction. DNA extraction was performed using the PowerSoil® DNA Isolation Kit (MoBio, Carlsbad, CA) according to the manufacturer's instructions. Each extracted genomic DNA was eluted in 100 μl of the elution buffer provided with the kit and stored at −20° C. until analysis.

[0076] (16S rRNA gene sequencing and sequence data processing) Amplicons were prepared according to the “Illumina 16S Metagenomic Sequencing Library Preparation Guide” using a primer set (27Fmod: 5′- AGRGTTTGATCMTGGCTCAG -3′ (R=G or A, M=A or C) (SEQ ID NO: 1) and 338R: 5′- TGCTGCCTCCCGTAGGAGT -3′ (SEQ ID NO: 2)) targeting the V1-V2 region of the 16S rRNA gene. 251 bp paired-end sequencing of the prepared amplicons was performed on a MiSeq (Illumina) using the MiSeq v2 500 cycle kit. Paired-end sequences were merged using PEAR (http: / / sco.h-its.org / exelixis / web / software / pear / ). The merged reads were then quality trimmed using BBtrim (bbmap.sourceforge.net). 20,000 reads per specimen were randomly selected using random_sequence_sample.pl (ualberta.ca / ~stothard / software.html) for further analysis. Processed reads were clustered into OTUs with a sequence similarity threshold defined at 97% using UCLUST version 1.2.22q. Representative sequences of each OUT were then taxonomically classified by using RDP Classifier version 2.2 with the Greengenes 13_8 database. Bioinformatics pipeline QIIME version 1.9.1 was used as the informatics environment for all relevant processing of the raw sequencing data.

[0077] (statistical analysis) Data are presented as mean ± SE. Statistical analysis was performed using JMP software version 9.0 (SAS Inc, Cary, North Carolina, USA) and R software environment (public domain, http: / / cran.r-project.org / ) version 3.1.3. To find the differential characteristics of microbiota between disease and healthy groups, the categorized data were analyzed by linear discriminant analysis (LDA) effect size (LefSe) (Harvard group) analysis (a < 0.01).

[0078] 〔result〕 (16S rRNA gene sequencing and data processing results, and stability of bacterial constituents) A total of 18,851,375 raw 16S rRNA gene sequences were obtained, which after quality filtering yielded a total of 13,094,927 paired-end sequences, with an average of 53,231 sequences per sample. To verify the stability of the microbiota at the four sites where samples were collected, the bacterial composition of samples collected at baseline and one month after baseline was compared with that of the healthy group. The results are shown in Figure 1. Figure 1 shows the relative abundance of each bacterial species at each site. As a result, no significant changes were observed in the bacterial composition at baseline and one month after baseline at any of the sites examined in this study. From these results, it can be understood that a stable microbiota was formed at the four sites examined in this study, and it was found that a stable microbiota similar to the intestinal microbiota is also present in ocular surface tissues such as the conjunctiva.

[0079] Next, we examined the effects of gender and left / right bias on the bacterial composition of the conjunctival microbial flora. The results are shown in Figures 2A and 2B. Figures 2A and 2B show the main bacteria that make up the microbial flora of the healthy and diseased groups, and also show the relative abundance ratios in graphs. As a result, no significant changes were observed in gender or left / right bias in either the healthy group (Figure 2A) or the diseased group (Figure 2B).

[0080] (Diversity and similarity of microbiota) The diversity of the microbiota in the four sites was examined at the department level for the healthy and disease groups. The results are shown in Figure 3. From the results, the numbers of microbiota in the conjunctiva, meibomian gland, periocular skin, and hands in the healthy group were 41.2 ± 0.86 (range 33-52), 48.6 ± 2.31 (range 32-65), 89.4 ± 5.14 (range 50-131), and 83.5 ± 5.11 (range 38-137), respectively. The numbers of microbiota in the conjunctiva, meibomian gland, periocular skin, and hands in the disease group were 39.4 ± 0.86 (range 30-51), 48.2 ± 2.48 (range 31-79), 80.8 ± 6.09 (range 47-187), and 87.4 ± 6.57 (range 55-140), respectively. Statistical analysis between the healthy and disease groups was performed by one-way ANOVA with Tukey post hoc analysis. There was no significant difference in the alpha diversity of the microbiota between the conjunctiva in the healthy and disease groups. The conjunctiva and meibomian glands showed lower alpha diversity than the periocular skin and hands (P < 0.01), whereas no significant difference was observed between the conjunctiva and meibomian glands. These results suggest that the microbiota of the conjunctiva and meibomian glands is less diverse than that of the body surface.

[0081] Next, to examine the similarity of the bacterial groups that make up the microbiota in β diversity, we performed principal component analysis (PCA) and clustered the top 11 bacterial species at the four sites where the samples were collected. The results are shown in Figures 4A and 4B. The results revealed the distances between the conjunctiva, meibomian gland, periocular skin, and hands from which the samples were collected in the healthy and disease groups at the family level. In detail, in the healthy and disease groups, relatively small distances were observed between the conjunctiva and meibomian gland, and between the periocular skin and hands. A large distance was observed between the conjunctiva and hands. Meanwhile, the separation between the conjunctiva and hands could be understood on the PCA plot.

[0082] (Differences in genus-level microbiota between healthy and diseased groups in four body regions analyzed by LEfSe) LEfSe analysis was performed to verify the difference in bacterial composition in the microbiota between the healthy and disease groups. The results are shown in Figure 5, which shows a bar graph showing the LDA score and a phylogenetic tree diagram including a biological classification hierarchy. The bar graph shows the genus level classification of bacteria that significantly increased and decreased in the disease group, and the LDA score was plotted on the phylogenetic tree diagram. As a result, the presence of Delftia, Xylophilus, Simplicispira, Rothia, and Xanthomonas was significantly higher in the conjunctiva of the disease group than in the healthy group, and the presence of Bacteroides, Clostridium, Deinococcus, Williamsia, Parabacteroides, Chryseobacterium, and Herbaspirillum was significantly lower. On the other hand, in the meibomian gland, the presence of Delftia, Clostridium, and Brevundimonas bacteria was significantly higher, whereas the presence of Schnedllella and Lactobacillus bacteria was significantly lower.In the periocular skin, the presence of Delftia bacteria was significantly higher, whereas the presence of Exiguobacterium bacteria was significantly lower.

[0083] Furthermore, the differences in bacterial composition in the microbiota between the healthy group and the disease group were examined in more detail. The results are shown in Figures 6A and 6B, and the proportion of each bacterial species is shown in a box plot. Here, in Figures 6A and 6B, the relative occupancy (%) of each bacterium to the bacterial group present at each site is shown on the vertical axis. As a result, the presence of Delftia bacteria was detected in many of the healthy and disease groups, and the presence of Xylophilus bacteria, Simplicispira bacteria, Rothia bacteria, and Xanthomonas bacteria was very rare in both groups (Figure 6A). It was also confirmed that the presence of the above five types of bacteria in the disease group was statistically higher than that of the healthy group. On the other hand, the presence of Bacteroides, Parabacteroides, Clostridium, Williamsia, Deinococcus, Chryseobacterium, and Herbaspirillum was mainly detected in the healthy group and was rare in the diseased group (Figure 6B).The presence of the above seven types of bacteria in the diseased group was confirmed to be statistically lower than that in the healthy group.

[0084] From the above results, it was understood that resident microbial flora exists in the internal habitat of each part examined in this study, and that resident microbial flora also exists on the ocular surface, such as the conjunctiva, and protects against the invasion of foreign bacteria. It was also confirmed that the bacterial composition of the microbial flora differs between healthy subjects and those with conjunctival MALT lymphoma. Therefore, it can be understood that by analyzing the microbial community structure of the ocular surface tissue of subjects, it is possible to detect subjects who have developed conjunctival MALT lymphoma or subjects at risk of developing conjunctival MALT lymphoma in the future based on the abundance and proportion of the constituent microorganisms.

[0085] As confirmed above, the conjunctival MALT lymphoma group showed a significantly higher abundance of certain bacterial species, specifically, the genus Delftia, and lower abundance of the genus Bacteroides and Clostridium in the microbial community structure of the microbiota than the healthy group. This suggests that Delftia may play a pathophysiological role in the development of conjunctival MALT lymphoma, and that Bacteroides and Clostridium may be protective factors for conjunctival MALT lymphoma. Thus, although the conjunctival microbiota is constantly fluctuating to maintain local homeostasis, dysbiosis may play an important role in the pathophysiology of conjunctival MALT lymphoma.

[0086] [Example 2] Changes in tear properties in conjunctival MALT lymphoma In this example, we investigated the relationship between changes in tear properties and the onset of conjunctival MALT lymphoma. Specifically, we analyzed the pH and IgA concentration of human tears and compared them between healthy subjects and patients with conjunctival MALT lymphoma.

[0087] [Changes in tear pH] In Example 1, it was confirmed that the number of bacteria belonging to the genus Delftia in the microbial community structure of the microbiota was significantly higher in the conjunctival MALT lymphoma disease group than in the healthy group. Delftia bacteria are bacteria present in soil, water, and living environments (Mahmood S. et al., J. Clin. Microbiol., 2012, 50(11), p3799-3800), and have been reported to have the ability to modify organic acids and amino acid residues (Sabine Leibeling et al., Environ. Sci. Technol., 2010, 44(10), p3793-3799). Based on the characteristics of Delftia bacteria, it was hypothesized that the pH of tears of patients with conjunctival MALT lymphoma, in which the number of Delftia bacteria is significantly increased in the microbial community structure, would decrease, and the following study was performed.

[0088] (method) A diseased group and healthy subjects were selected in the same manner as in Example 1, and the tear pH of the diseased group (N=28) and the healthy group (N=26) was measured using a pH meter (LAQUA twin B-731: Horiba, Ltd.), and the presence of significant differences between the two groups was analyzed using the Wilcoxon rank sum test.

[0089] (result) The results are shown in Figure 7. As a result, the average pH in the healthy group was 7.46, while that in the diseased group was 7.14, confirming that the tear pH of patients with conjunctival MALT lymphoma was significantly lower.

[0090] [Changes in tear IgA concentration] In Example 1, it was confirmed that the microbial community structure of the microbiota in the conjunctival MALT lymphoma disease group had significantly lower levels of bacteria belonging to the genus Bacteroides and Clostridium than in the healthy group. It has been reported that Bacteroides bacteria constitute the intestinal microbiota, activate regulatory T cells (T-reg) / Th17, and trigger the control of inflammatory responses (Abby L. Geis et al., Cancer Discov., 5(10), p1098-1109). In addition, there are other reports that they are involved in antibody production and inflammatory response control (Rol N. et al., J. Biol. Chem., 2012, 287(47), p40074-40082; Sara Omenetti et al., Front. Immunol., 2015, 6, Article 639). On the other hand, it has been reported that Clostridium bacteria induce T-regs by administration and are involved in maintaining immunity (Taylor Feehley et al., Curr. Opin. Lmmunol., 2014, 31, p79-86). There are also other reports that they are involved in suppressing allergic reactions (Ouwehand AC. et al., World J. Gastroenterol., 2009, 15(26), 3261-3268, and Stefka AT. et al., Proc. Natl. Acad. Sci. USA, 111(36), p13145-13150). Based on these characteristics of Bacteroides and Clostridium, we hypothesized that patients with conjunctival MALT lymphoma, in which the microbial community structure of Bacteroides and Clostridium is significantly reduced, have a weakened immune system, and conducted the following study.

[0091] (method) A disease group and healthy subjects were selected in the same manner as in Example 1, and the IgA concentrations in the tears of the disease group (N=28) and the healthy group (N=26) were measured using an ELISA kit for measuring human IgA. The presence of significant differences between the two groups was analyzed using the Wilcoxon rank-sum test.

[0092] (result) The results are shown in Figure 8. As a result, the tear IgA concentration was significantly lower in the diseased group compared to the healthy group. This confirmed that the IgA concentration in the tears of patients with conjunctival MALT lymphoma was significantly lower, indicating that their immune function was impaired.

[0093] Changes in the microbial community structure of the microbiota in the ocular surface tissue may lead to changes in the conjunctival environment. In the conjunctival MALT lymphoma examined in this study, Delftia spp. is an attacking factor that can be the starting point of inflammation as a pathogen, while Bacteroides spp. and Clostridium spp. may be defensive factors through activation of T-reg / Th17, control of inflammatory responses, and induction of IgA production. In the microbial community structure, a change in the balance between the attacking factor Delftia spp. and the defensive factors Bacteroides spp. and Clostridium spp. may be involved in the onset of conjunctival MALT lymphoma.

[0094] Based on the above results, a multivariate analysis was performed on three types of bacteria involved in the development of conjunctival MALT lymphoma, namely, Delftia spp., Bacteroides spp., and Clostridium spp. Here, the clinical parameters of age, sex, and laterality in patients with conjunctival MALT lymphoma were analyzed, and p-values ​​were calculated. If the p-value was 0.05 or less, it was determined that there was a correlation. The results are shown in Table 2. As shown in Table 2, no significant differences were observed in the clinical parameters examined this time, supporting the fact that the change in microbial community structure confirmed in Example 1 is not dependent on age, sex, or laterality, but is specific to conjunctival MALT lymphoma. Therefore, it is supported that the change in microbial community structure, including Delftia spp., Bacteroides spp., and Clostridium spp., is involved in the development of conjunctival MALT lymphoma.

[0095] [Table 2]

[0096] [Example 3] Changes in the microbial flora (fungal flora) in conjunctival MALT lymphoma In this example, we investigated the relationship between changes in the ocular surface tissue microbiota and the onset of conjunctival MALT lymphoma. Specifically, we analyzed the microbial community structure (fungi) contained in samples collected from human ocular surface tissue using ITS region genes and compared the results between healthy subjects and patients with conjunctival MALT lymphoma.

[0097] (method) A disease group and healthy subjects were selected in the same manner as in Example 1. Analysis of the microbiota of the ocular surface tissue (conjunctiva) of the disease group (N = 50) and the healthy group (N = 50) was performed by (sample collection and DNA isolation), (ITS region sequencing and data processing), and (statistical analysis) in the same manner as in Example 1. In addition, ITS region sequencing was performed by preparing each amplicon using a primer set (ITS1-F: 5'-CTTGGTCATTTAGAGGAAGTAA -3' (SEQ ID NO: 3)) and (ITS2: 5'-GCATCGATGAAGAACGCAGC -3' (SEQ ID NO: 4)) targeting the ITS region in rRNA, and sequencing was performed on MiSeq (Illumina) using the MiSeq v2 500 cycle kit.

[0098] (result) The fungal composition of the specimens taken from the human ocular surface tissues of the healthy and diseased groups was compared at the genus level. The results are shown in FIG. 9 and FIG. 10A to FIG. 10C. In FIG. 9, the main fungi constituting the microbial layer of the healthy and diseased groups are indicated, and the relative abundance ratios are shown in a graph. FIG. 10A to FIG. 10C show the results of comparing the abundance ratios of three fungi, Malassezia, Byssochlamys, and Aspergillus, which had the highest abundance ratios, between the healthy and diseased groups. As a result, no significant variation in abundance ratio was confirmed between the diseased and healthy groups for any of the identified fungal species. Thus, no association was observed between the fungal composition in the microbiota structure of conjunctival MALT lymphoma, and the results of Examples 1 and 2 strongly support the fact that specific bacterial species, including Delftia, Bacteroides, and Clostridium, play an important role in the pathophysiology of conjunctival MALT lymphoma.

[0099] [Example 4] Changes in microbiota with age In this example, we investigated the relationship between age and changes in the microbial flora of ocular surface tissue. Specifically, we analyzed the microbial community structure in samples collected from human ocular surface tissue using the 16S rRNA gene and investigated the correlation between the microbial community structure and age.

[0100] (method) In this example, the ocular surface tissue microbiota of 38 healthy subjects (78 eyes) aged 21 to 83 years was analyzed by (sample collection and DNA isolation), (16S rRNA sequencing and data processing), and (statistical analysis) in the same manner as in Example 1. The healthy subjects consisted of 18 men and 21 women, with a mean age of 53.0±19.8 years, no history of eye disease, no contact lens wear, and no history of eye trauma.

[0101] (result) The bacterial composition of the conjunctival microflora from healthy subjects of each age was examined. The results are shown in Figures 11 to 13. As a result, it was confirmed that the bacterial composition of the conjunctival microflora from healthy subjects of each age changes with age, and that the number of Propionibacteriaceae bacteria decreases with age, while the number of Corynebacteriaceae bacteria increases. Figure 11 is a graph showing the age-related change in the occupancy rate of Propionibacteriaceae bacteria and Corynebacteriaceae bacteria in the conjunctiva. Figure 12 is a graph showing the age-related change in the ratio of Corynebacteriaceae bacteria / Propionibacteriaceae bacteria (C / P). Figure 13 is a graph showing the age-related change in the difference (CP) between Corynebacteriaceae bacteria and Propionibacteriaceae bacteria. From all of the results, a significant correlation with age was observed, and it can be seen that around the age of 60, the abundance of bacteria from the family Corynebacteriaceae was higher than that of bacteria from the family Propionibacteriaceae.

[0102] Furthermore, the age-related change in the difference (CP) between the Corynebacteriaceae family bacteria and the Propionibacteriaceae family bacteria was examined in four sites, namely the conjunctiva, meibomian gland, hand, and periocular skin. The results are shown in FIG. 14, which is a graph showing the age-related change in the difference (CP) between the Corynebacteriaceae family bacteria and the Propionibacteriaceae family bacteria in the conjunctiva, meibomian gland, hand, and periocular skin. As a result, the age-related change in the difference (CP) between the Corynebacteriaceae family bacteria and the Propionibacteriaceae family bacteria was observed in all sites, and the abundance of the Corynebacteriaceae family bacteria increased with age. However, the abundance of the Corynebacteriaceae family bacteria exceeded that of the Propionibacteriaceae family bacteria only in the ocular surface tissues of the conjunctiva and meibomian gland. From this, it can be understood that the ocular surface tissue can detect the aging state of the subject, and the difference is significant, so that the aging state of the subject can be detected with high reliability. In addition, the correlation with age was also analyzed for fungi in the microbial community structure, but no significant changes were confirmed for specific fungal species. This also strongly supports the above results that bacteria of the Corynebacteriaceae family and Propionibacteriaceae family are specifically related to the aging state and play a role as aging biomarkers. [Industrial Applicability]

[0103] The present invention can be used in all technical fields requiring detection of a conjunctival disease state and detection of an aging state, for example, prediction of the onset, onset risk, and progression of a conjunctival disease, investigation of the cause of a conjunctival disease, confirmation of the therapeutic effect of a medicine or the like for a conjunctival disease, and detection of physiological and pathological aging states, and is particularly applicable in the medical and pharmaceutical fields, etc.

Claims

1. A method for detecting an aging condition using an ocular surface tissue, comprising: A method for detecting an aging state, comprising a step of detecting an ocular surface tissue sample collected from a subject, the tissue sample being evaluated as being in an aging state when the abundance or abundance ratio of bacteria of the family Corynebacteriaceae exceeds the abundance or abundance ratio of bacteria of the family Propionibacteriaceae in a microbial flora contained in the ocular surface tissue sample collected from the subject.

2. The method for detecting an aging state according to claim 1, wherein the abundance or abundance ratio of the Corynebacteriaceae family bacteria is detected based on the base sequence of the 16S rRNA gene of the bacteria, and the abundance or abundance ratio of the Propionibacteriaceae family bacteria is detected based on the base sequence.

3. The method for detecting an aging state according to claim 1 or 2, wherein the aging state is a physiological aging state or a pathological aging state.

Citation Information

Patent Citations

  • Methods for determining degree of aging of intestinal flora and screening methods for microbial populations

    JP2015188379A

  • Method for evaluating physical conditions, method for presenting information, and method of screening for substance for improving or preventing physical conditions

    JP2017029133A

  • Method for evaluating physical conditions, method for presenting information, and method of screening for substance for improving or preventing physical conditions

    JP2017029174A